BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33171421)

  • 1. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13.
    Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Nakayama S; Kamei Y; Namba A; Murotsuki J; Yamaguchi M; Tairaku S; Maeda K; Kaji T; Okamoto Y; Endo M; Ogawa M; Kasai Y; Ichizuka K; Yamada N; Ida A; Miharu N; Kawaguchi S; Hasuo Y; Okazaki T; Ichikawa M; Izumi S; Kuno N; Yotsumoto J; Nishiyama M; Shirato N; Hirose T; Sago H
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():75-81. PubMed ID: 33171421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
    Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
    Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin.
    Kleinfinger P; Luscan A; Descourvieres L; Buzas D; Boughalem A; Serero S; Valduga M; Trost D; Costa JM; Vivanti AJ; Lohmann L
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.
    van Riel M; Brison N; Baetens M; Blaumeiser B; Boemer F; Bourlard L; Bulk S; De Leener A; Désir J; Devriendt K; Dheedene A; Duquenne A; Fieremans N; Fieuw A; Gatot JS; Grisart B; Janssens S; Khudashvili N; Lannoo L; Marichal A; Meunier C; Palmeira L; Parijs I; Pichon B; Roets E; Sammels E; Smits G; Suenaert M; Sznajer Y; Van den Bogaert K; Vancoillie L; Vandeputte L; Vantroys E; Vermeesch JR; Janssens K
    Obstet Gynecol; 2021 Jun; 137(6):1102-1108. PubMed ID: 33957658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
    Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
    J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the results of chromosomal trisomies 21, 18 and 13 screening among 40 628 women by non-invasive prenatal testing].
    Wang D; Yang J; Peng H; Hou Y; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1045-1050. PubMed ID: 34729740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of true and false positive Z values among high-risk cases screened by non-invasive prenatal testing].
    Mo J; Ren J; Yang L; Shen X; Zhao D; Xiao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1187-1191. PubMed ID: 36317201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of non-invasive prenatal testing for rare autosomal trisomies in fetuses].
    Xie X; Zhao Q; Hu L; Jiang S; Wang X; Zhang W; Li Z; You Y; Lu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2071-2077. PubMed ID: 38189393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing.
    Xue Y; Zhao G; Qiao L; Lu J; Yu B; Wang T
    Front Genet; 2020; 11():280. PubMed ID: 32273885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results.
    Hartwig TS; Ambye L; Werge L; Weiergang MK; Nørgaard P; Sørensen S; Jørgensen FS
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():35-39. PubMed ID: 29804026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
    Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
    Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
    Samura O; Okamoto A
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.
    Ma J; Wang Y; Wang W; Dong Y; Xu C; Zhou A; Xu Z; Wu Z; Tang X; Chen F; Yin Y; Wang W; Yan M; Zhang W; Mu F; Yang H
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):49-57. PubMed ID: 27363706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.
    Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Kuriki H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Endo M; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Nishikawa N; Hamajima N; Shirato N; Yotsumoto J; Nishiyama M; Koide K; Hirose T; Sago H
    Prenat Diagn; 2019 Jan; 39(2):100-106. PubMed ID: 30586157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.